Showing results (101-110 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|March 23, 2016
Significance of CD99 expression in T-lineage acute lymphoblastic leukemiaAzza A Aboul Enein, Hala A Abdel Rahman, Nahla El Sharkawy, et al.Cancer Biomarkers : Section a of Disease Markers|April 11, 2016
KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancerKaren Bento Ribeiro, Juliana da Silva Zanetti, Alfredo Ribeiro-Silva, et al.Cancer Biomarkers : Section a of Disease Markers|April 11, 2016
Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluidJohnny C Akers, Valya Ramakrishnan, Isaac Yang, et al.Cancer Biomarkers : Section a of Disease Markers|April 11, 2016
Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinomaBin-Hui Xie, Xiao He, Rui-Xi Hua, et al.Cancer Biomarkers : Section a of Disease Markers|April 11, 2016
Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancerSehhoon Park, Seongyeol Park, Se-Hoon Lee, et al.Cancer Biomarkers : Section a of Disease Markers|April 11, 2016
Prognostic significance of CLPTM1L expression and its effects on migration and invasion of human lung cancer cellsZhenhua Ni, Qingge Chen, Yiming Lai, et al.Cancer Biomarkers : Section a of Disease Markers|June 18, 2016
Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitisJana Rychlíková, Marek Vecka, Marie Jáchymová, et al.Cancer Biomarkers : Section a of Disease Markers|June 18, 2016
Use of the cell cycle progression (CCP) score for predicting systemic disease and response to radiation of biochemical recurrenceMichael O Koch, Jane S Cho, Hristos Z Kaimakliotis, et al.Cancer Biomarkers : Section a of Disease Markers|May 20, 2019
Using tRNA halves as novel biomarkers for the diagnosis of gastric cancerLinwen Zhu, Tianwen Li, Yijing Shen, et al.Cancer Biomarkers : Section a of Disease Markers|May 20, 2019
Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancerYi Li, Xiaomei Su, Haixia PanPageof 192